| Control | T1 (presentation) | T2 (12 h) | T3 (24 h) | T4 (36 h) | T5 (14 days) |
---|---|---|---|---|---|---|
sCr (μmol/L) | 88.4 (44.2–150.3) | 70.7 (53–106) | 61.88 (53–97.2) | 66.3 (44.2–88.4) | 70.7 (44.2–97.2) | 79.6 (53–123.8) |
SDMA (μmol/L) | 0.54 (0.35–0.74) | 0.5 (0.35–0.64) | 0.47 (0.25–0.64) | 0.45 (0.25–0.64) | 0.4 (0.25–0.69) | 0.54 (0.3–0.84) |
uKIM-1/uCr (ng/mg) | 0.13 (0.013–0.36) |  | 0.13 (0.001–0.2) | 0.15 (0.002–0.32) | 0.20 (0.008–0.35) | 0.14 (0.03–0.25) |
uOPN/uCr (ng/mg) | 1.86 (0.13–4.2) |  | 2.54 (0.08–7.96) | 5.22 (0.22–24.87) | 6.34 (0.5–31.86) | 1.88 (0.26–15.46) |
uCysC/uCr (ng/mg) | 0.95 (0.16–3.74) |  | 0.66 (0.22–1.43) | 0.57 (0.17–2.94) | 0.56 (0.24–1.78) | 0.58 (0.17–2.39) |
uNGAL/uCr (ng/mg) | 0.21 (0.02–2.94) |  | 2.8 (0.1–15.78) | 2.1 (0.07–3.02) | 2.62 (0.09–21.66) | 0.28 (0.03–23.3) |
uMCP-1/uCr (ng/mg) | 0.46 (0.05–1.97) |  | 0.8 (0.15–5.44) | 0.78 (0.23–7.24) | 0.88 (0.27–5.58) | 0.6 (0.09–6.14) |
uGGT/uCr (U/g) | 15.4 (0.95–75.26) |  | 30.14 (3.96–83.44) | 21.6 (0–85.65) | 28.52 (9–120.5) | 18.27 (0–48.83) |
uALB/uCr mg/g | 0.005 (0.002–6) 32/34 (94.1%) < LOQ* |  | 0.019 (0.03–289) 9/16 (56%) < LOQ | 0.036 (0.004–116) 16/25 (64%) <LOQ | 0.025 (0.01–175) 17/22 (77%) < LOQ | 0.007 (0.004–124) 16/19 (84%) < LOQ |
uIL-8/uCr (ng/mg) | 0.06 (0.02–0.9) 18/34 (52.9%) < LOQ** |  | 0.08 (0.02–0.29) 10/16 (62.5%) < LOQ | 0.14 (0.03–1.62) 21/24 (87.5%) < LOQ | 0.14 (0.05–0.79) 18/22 (81.8%) < LOQ | 0.07 (0.03–3.37) 14/20 (70%) < LOQ |
uALP/uCr (U/g) | 100% < LOQ*** |  | 100% < LOQ | 100% < LOQ | 96% < LOQ | 100% < LOQ |